Clements Ip

Q: What Schools Are Affiliated With Clements Ip

Clements Ip is affiliated with the following schools: Jilin University, Washington State University, University of Massachusetts

Clements Ip's AcademicInfluence.com Rankings

Clements Ip

Biology

#10431

World Rank

#13761

Historical Rank

Molecular Biology

#1514

World Rank

#1541

Historical Rank

biology Degrees

Download Badge

Biology

Clements Ip's Degrees

PhD Molecular Biology Stanford University

Why Is Clements Ip Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Clements Ip's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Mammary cancer prevention by conjugated dienoic derivative of linoleic acid. (1991) (824)
Lessons from basic research in selenium and cancer prevention. (1998) (677)
Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat. (1994) (615)
Conjugated linoleic acid-enriched butter fat alters mammary gland morphogenesis and reduces cancer risk in rats. (1999) (471)
In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention. (2000) (408)
Requirement of essential fatty acid for mammary tumorigenesis in the rat. (1985) (323)
Chemical form of selenium, critical metabolites, and cancer prevention. (1991) (308)
Chemical speciation influences comparative activity of selenium-enriched garlic and yeast in mammary cancer prevention. (2000) (295)
Human prx1 gene is a target of Nrf2 and is up-regulated by hypoxia/reoxygenation: implication to tumor biology. (2007) (238)
Activity of methylated forms of selenium in cancer prevention. (1990) (222)
The efficacy of conjugated linoleic acid in mammary cancer prevention is independent of the level or type of fat in the diet. (1996) (217)
Mammary cancer prevention by regular garlic and selenium-enriched garlic. (1992) (214)
cis-9, trans-11 CLA derived endogenously from trans-11 18:1 reduces cancer risk in rats. (2003) (208)
Selenium‐induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake (1999) (206)
Review of the effects of trans fatty acids, oleic acid, n-3 polyunsaturated fatty acids, and conjugated linoleic acid on mammary carcinogenesis in animals. (1997) (205)
Delineation of the molecular basis for selenium-induced growth arrest in human prostate cancer cells by oligonucleotide array. (2003) (200)
Effect of timing and duration of dietary conjugated linoleic acid on mammary cancer prevention. (1995) (199)
Cancer-protective properties of high-selenium broccoli. (2001) (198)
Synergistic effect of vitamin E and selenium in the chemoprevention of mammary carcinogenesis in rats. (1983) (189)
Decrease in linoleic acid metabolites as a potential mechanism in cancer risk reduction by conjugated linoleic acid. (1999) (185)
New Concepts in Selenium Chemoprevention (2004) (174)
Conjugated linoleic acid inhibits proliferation and induces apoptosis of normal rat mammary epithelial cells in primary culture. (1999) (169)
Distribution of conjugated linoleic acid and metabolites in different lipid fractions in the rat liver. (2001) (161)
Conjugated Linoleic Acid Isomers and Mammary Cancer Prevention (2002) (159)
Prophylaxis of mammary neoplasia by selenium supplementation in the initiation and promotion phases of chemical carcinogenesis. (1981) (148)
Morphological and biochemical status of the mammary gland as influenced by conjugated linoleic acid: implication for a reduction in mammary cancer risk. (1997) (147)
Human Peroxiredoxin 1 and 2 Are Not Duplicate Proteins (2007) (144)
The anticarcinogenic effect of trans-11 18:1 is dependent on its conversion to cis-9, trans-11 CLA by delta9-desaturase in rats. (2004) (142)
Prx1 suppresses radiation-induced c-Jun NH2-terminal kinase signaling in lung cancer cells through interaction with the glutathione S-transferase Pi/c-Jun NH2-terminal kinase complex. (2006) (140)
Comparison of selenium and sulfur analogs in cancer prevention. (1992) (139)
Prostate Specific Antigen Expression Is Down-Regulated by Selenium through Disruption of Androgen Receptor Signaling (2004) (134)
Identification of molecular targets associated with selenium-induced growth inhibition in human breast cells using cDNA microarrays. (2002) (134)
Retention of conjugated linoleic acid in the mammary gland is associated with tumor inhibition during the post-initiation phase of carcinogenesis. (1997) (129)
Vaccenic Acid Feeding Increases Tissue Levels of Conjugated Linoleic Acid and Suppresses Development of Premalignant Lesions in Rat Mammary Gland (2001) (127)
Conjugated linoleic acid and linoleic acid are distinctive modulators of mammary carcinogenesis. (1997) (125)
Induction of apoptosis by conjugated linoleic acid in cultured mammary tumor cells and premalignant lesions of the rat mammary gland. (2000) (121)
Synergy between selenium and vitamin E in apoptosis induction is associated with activation of distinctive initiator caspases in human prostate cancer cells. (2003) (119)
Enhancement of mammary tumorigenesis by dietary selenium deficiency in rats with a high polyunsaturated fat intake. (1981) (118)
Endoplasmic reticulum stress signal mediators are targets of selenium action. (2005) (117)
Prevention of Mammary Cancer with Conjugated Linoleic Acid: Role of the Stroma and the Epithelium (2004) (117)
Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substrates (2007) (113)
Enhanced selenium effect on growth arrest by BiP/GRP78 knockdown in p53-null human prostate cancer cells (2006) (110)
Fat and essential fatty acid in mammary carcinogenesis. (1987) (108)
Enrichment of selenium in allium vegetables for cancer prevention. (1994) (98)
Alterations in serum glycosyltransferases and 5'-nucleotidase in breast cancer patients. (1978) (98)
Comparative effect of inorganic and organic selenocyanate derivatives in mammary cancer chemoprevention. (1994) (97)
Milk fatty acids and human health: Potential role of conjugated linoleic acid and trans fatty acids (2006) (95)
Factors influencing the anticarcinogenic efficacy of selenium in dimethylbenz[a]anthracene-induced mammary tumorigenesis in rats. (1981) (93)
Tumorigenesis, metabolism, speciation, bioavailability, and tissue deposition of selenium in selenium-enriched ramps (Allium tricoccum). (2000) (92)
Comparative effects of different animal and vegetable fats fed before and during carcinogen administration on mammary tumorigenesis, sexual maturation, and endocrine function in rats. (1986) (91)
Inhibition of angiogenesis by the cancer chemopreventive agent conjugated linoleic acid. (2002) (90)
Efficacy of cancer prevention by high-selenium garlic is primarily dependent on the action of selenium. (1995) (90)
Methyl selenium metabolites decrease prostate-specific antigen expression by inducing protein degradation and suppressing androgen-stimulated transcription. (2004) (90)
Selenium modulation of cell proliferation and cell cycle biomarkers in normal and premalignant cells of the rat mammary gland. (2000) (88)
Methylseleninic Acid Potentiates Apoptosis Induced by Chemotherapeutic Drugs in Androgen-Independent Prostate Cancer Cells (2005) (87)
The Chemopreventive Role of Selenium in Carcinogenesis (1986) (87)
Isomers of conjugated linoleic acid differ in their effects on angiogenesis and survival of mouse mammary adipose vasculature. (2004) (87)
Dietary intake of conjugated linoleic acids and risk of premenopausal and postmenopausal breast cancer, Western New York Exposures and Breast Cancer Study (WEB Study). (2004) (87)
Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate‐specific antigen (PSA) (2006) (84)
Chemoprevention of mammary tumorigenesis by a combined regimen of selenium and vitamin A. (1981) (83)
Ability of dietary fat to overcome the resistance of mature female rats to 7,12-dimethylbenz(a)anthracene-induced mammary tumorigenesis. (1980) (83)
Tissue selenium levels in selenium-supplemented rats and their relevance in mammary cancer protection. (1989) (83)
Chemoprevention of mammary cancer with Se-allylselenocysteine and other selenoamino acids in the rat. (1999) (80)
AMPK-mediated autophagy is a survival mechanism in androgen-dependent prostate cancer cells subjected to androgen deprivation and hypoxia. (2011) (80)
Anticarcinogenic effect of selenium in rats treated with dimethylbenz[a]anthracene and fed different levels and types of fat. (1981) (80)
Androgen receptor signaling intensity is a key factor in determining the sensitivity of prostate cancer cells to selenium inhibition of growth and cancer-specific biomarkers (2005) (79)
Selenium-enriched garlic inhibits the early stage but not the late stage of mammary carcinogenesis. (1996) (77)
Peroxiredoxin 1 interacts with androgen receptor and enhances its transactivation. (2007) (77)
Hypoxia increases androgen receptor activity in prostate cancer cells. (2006) (75)
Metabolites of sodium selenite and methylated selenium compounds administered at cancer chemoprevention levels in the rat. (1993) (74)
Selenium inhibition of chemical carcinogenesis. (1985) (73)
Up-regulation of c-Jun-NH2-kinase pathway contributes to the induction of mitochondria-mediated apoptosis by alpha-tocopheryl succinate in human prostate cancer cells. (2005) (72)
A comparison of the effects of the prostaglandin synthesis inhibitors indomethacin and carprofen on 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis in rats fed different amounts of essential fatty acid. (1989) (69)
The chemopreventive role of selenium in carcinogenesis. (1986) (69)
The t10,c12 isomer of conjugated linoleic acid stimulates mammary tumorigenesis in transgenic mice over-expressing erbB2 in the mammary epithelium. (2007) (69)
Modulation of phase I and phase II xenobiotic-metabolizing enzymes by selenium-enriched garlic in rats. (1997) (65)
Delineating the mechanism by which selenium deactivates Akt in prostate cancer cells (2006) (65)
Selenium disrupts estrogen signaling by altering estrogen receptor expression and ligand binding in human breast cancer cells. (2005) (65)
Dietary vitamin E intake and mammary carcinogenesis in rats. (1982) (65)
Characterization of tissue selenium profiles and anticarcinogenic responses in rats fed natural sources of selenium-rich products. (1994) (64)
Serum sialyltransferase and 5'-nucleotidase as reliable biomarkers in women with breast cancer. (1980) (64)
Role of prolactin in the promotion of dimethylbenz[a]anthracene-induced mammary tumors by dietary fat. (1980) (61)
Methylselenocysteine modulates proliferation and apoptosis biomarkers in premalignant lesions of the rat mammary gland. (2001) (60)
Bioactivity of selenium from Brazil nut for cancer prevention and selenoenzyme maintenance. (1994) (60)
Similarity between trans fat and saturated fat in the modification of rat mammary carcinogenesis. (1984) (54)
Effects of selenium on 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis and DNA adduct formation. (1985) (53)
Detection of conjugated C16 PUFAs in rat tissues as possible partial beta-oxidation products of naturally occurring conjugated linoleic acid and its metabolites. (2004) (52)
Control of Rat Mammary Epithelium Proliferation by Conjugated Linoleic Acid (2001) (52)
Mammary cancer chemoprevention by inorganic and organic selenium: single agent treatment or in combination with vitamin E and their effects on in vitro immune functions. (1987) (51)
Combination of blocking agents and suppressing agents in cancer prevention. (1991) (50)
Survival advantage of AMPK activation to androgen-independent prostate cancer cells during energy stress. (2010) (49)
Serum estrogens and estrogen responsiveness in 7,12-dimethylbenz[a]anthracene-induced mammary tumors as influenced by dietary fat. (1981) (49)
Chemotherapeutic sensitization by endoplasmic reticulum stress: Increasing the efficacy of taxane against prostate cancer (2009) (47)
High superoxide dismutase and low glutathione peroxidase activities in red blood cells predict susceptibility of lung cancer patients to radiation pneumonitis. (2007) (47)
Efficacy of trimethylselenonium versus selenite in cancer chemoprevention and its modulation by arsenite. (1988) (46)
Interaction of vitamin C and selenium supplementation in the modification of mammary carcinogenesis in rats. (1986) (46)
Increase in serum and tissue glycosyltransferases and glycosidases in tumor-bearing rats. (1977) (46)
Dietary selenium intake and growth of the MT-W9B transplantable rat mammary tumor. (1981) (46)
Androgen receptor-mTOR crosstalk is regulated by testosterone availability: implication for prostate cancer cell survival. (2010) (46)
Differential effect of dietary methionine on the biopotency of selenomethionine and selenite in cancer chemoprevention. (1988) (45)
Trans fatty acids and cancer. (2009) (44)
Microarray Data Mining for Potential Selenium Targets in Chemoprevention of Prostate Cancer. (2005) (42)
Selenium disrupts estrogen receptor α signaling and potentiates tamoxifen antagonism in endometrial cancer cells and tamoxifen-resistant breast cancer cells (2005) (41)
Cancer chemoprevention by aliphatic selenocyanates: effect of chain length on inhibition of mammary tumors and DMBA adducts. (1995) (41)
Quantitative assessment of fat and calorie as risk factors in mammary carcinogenesis in an experimental model. (1990) (41)
Conjugated linoleic acid induces apoptosis of murine mammary tumor cells via Bcl-2 loss. (2007) (40)
Prx1 Enhances Androgen Receptor Function in Prostate Cancer Cells by Increasing Receptor Affinity to Dihydrotestosterone (2009) (40)
Triphenylselenonium and diphenylselenide in cancer chemoprevention: comparative studies of anticarcinogenic efficacy, tissue selenium levels and excretion profile. (1997) (39)
Controversial issues of dietary fat and experimental mammary carcinogenesis. (1993) (38)
Activities of structurally-related lipophilic selenium compounds as cancer chemopreventive agents. (1998) (37)
Bioavailability of selenium from selenium-enriched garlic. (1993) (37)
Current Concepts of Selenium and Mammary Tumorigenesis (1987) (37)
Selenium and experimental cancer. (1986) (37)
Telomerase as an Important Target of Androgen Signaling Blockade for Prostate Cancer Treatment (2010) (35)
Potential of food modification in cancer prevention. (1994) (34)
Thioredoxin reductase activity in rat liver is not affected by supranutritional levels of monomethylated selenium in vivo and is inhibited only by high levels of selenium in vitro. (2001) (34)
Effects of high dietary fat on the growth and development of ovarian-independent carcinogen-induced mammary tumors in rats. (1986) (34)
Prostate cancer cells differ in testosterone accumulation, dihydrotestosterone conversion, and androgen receptor signaling response to steroid 5α‐reductase inhibitors (2013) (34)
Concurrent deregulation of gelsolin and cyclin D1 in the majority of human and rodent breast cancers (1999) (33)
Feasibility of using lower doses of chemopreventive agents in a combination regimen for cancer protection. (1988) (32)
Doxorubicin and selenium cooperatively induce fas signaling in the absence of Fas/Fas ligand interaction. (2007) (32)
An increase in vitamin A status by the feeding of conjugated linoleic acid. (1999) (32)
Impact of dietary conjugated linoleic acid on the oxidative stability of rat liver microsomes and skeletal muscle homogenates. (2000) (31)
Novel Strategies in Selenium Cancer Chemoprevention Research (1994) (29)
Methyl Selenocysteine: Single-Dose Pharmacokinetics in Men (2011) (28)
Biological activities of trimethylselenonium as influenced by arsenite. (1992) (28)
Attenuation of Estrogen Receptor α (ERα) Signaling by Selenium in Breast Cancer Cells via Downregulation of ERα Gene Expression (2005) (28)
20(S)‐protopanaxadiol‐aglycone downregulation of the full‐length and splice variants of androgen receptor (2013) (28)
Neoplastic growth of carcinogen-treated mammary transplants as influenced by fat intake of donor and host. (1981) (27)
Attenuation of the anticarcinogenic action of selenium by vitamin E deficiency. (1985) (26)
Comparative effects of antioxidants on enzymes involved in glutathione metabolism. (1984) (26)
Cell cycle arrest biomarkers in human lung cancer cells after treatment with selenium in culture. (2003) (26)
Activation of FOXO1 is critical for the anticancer effect of methylseleninic acid in prostate cancer cells (2010) (25)
Chemoprevention with triphenylselenonium chloride in selenium-deficient rats. (2000) (25)
Mammary tumorigenesis and chemoprevention studies in carcinogen-treated rats (2005) (25)
Relevance of trans fatty acids and fish oil in animal tumorigenesis studies. (1986) (25)
The antiandrogenic effect of finasteride against a mutant androgen receptor (2011) (24)
Evidence of a field effect associated with mammary cancer chemoprevention by methylseleninic acid. (2002) (24)
Dietary fat and cancer (1986) (23)
The attributes of selenium-enriched garlic in cancer prevention. (1996) (23)
Cellular and molecular effects of alpha-tocopheryloxybutyrate: lessons for the design of vitamin E analog for cancer prevention. (2004) (21)
The transcriptomics of de novo androgen biosynthesis in prostate cancer cells following androgen reduction (2010) (20)
The t 10 , c 12 isomer of conjugated linoleic acid stimulates mammary tumorigenesis in transgenic mice overexpressing erbB 2 in the mammary epithelium (2007) (19)
Exercise training and the differential prolactin response in male and female rats. (1989) (19)
Effect of estradiol and prolactin on galactosyltransferase and alpha-lactalbumin activities in rat mammary gland and mammary tumor. (1978) (19)
Activity of triphenylselenonium chloride in mammary cancer prevention. (1994) (19)
New approaches to cancer chemoprevention with difluoromethylornithine and selenite. (1989) (18)
Inhibition of mammary tumorigenesis by a reduction of fat intake after carcinogen treatment in young versus adult rats. (1980) (18)
Free amino acid pools of rodent mammary tumors. (1982) (16)
Yield of Terminal Duct Lobule Units in Normal Breast Stereotactic Core Biopsy Specimens: Implications for Biomarker Studies (2000) (16)
Targeting the Nrf2-Prx1 Pathway with Selenium to Enhance the Efficacy and Selectivity of Cancer Therapy (2007) (16)
Cytostasis and cancer chemoprevention: investigating the action of triphenylselenonium chloride in in vivo models of mammary carcinogenesis. (1998) (15)
A Display Thiol-Proteomics Approach to Characterize Global Redox Modification of Proteins by Selenium: Implications for the Anticancer Action of Selenium. (2005) (15)
Analysis of Protein Redox Modification by Hypoxia (2006) (14)
Interaction of dietary fat and the thymus in the induction of mammary tumors by 7,12-dimethylbenz(a)anthracene. (1982) (14)
The direct inhibitory effect of dutasteride or finasteride on androgen receptor activity is cell line specific (2013) (12)
Temporal changes in tissue glutathione in response to chemical form, dose, and duration of selenium treatment (1991) (11)
Attenuation of estrogen receptor alpha (ERalpha) signaling by selenium in breast cancer cells via downregulation of ERalpha gene expression. (2005) (11)
Activity of Se‐allylselenocysteine in the presence of methionine γ‐lyase on cell growth, DNA integrity, apoptosis, and cell‐cycle regulatory molecules (2000) (11)
Regulation of cyclic adenosine 3',5'-monophosphate in relation to growth of dimethylbenz[a]anthracene-induced mammary tumors in rats. (1980) (10)
Neural Network‐Based Analysis of Thiol Proteomics Data in Identifying Potential Selenium Targets (2006) (9)
Levels and 75Se-Labeling of Specific Proteins as a Consequence of Dietary Selenium Concentration in Mice and Rats (1991) (9)
High SOD and low GPX activities in RBC predict susceptibility of lung cancer patients to radiation pneumonitis (2007) (9)
Isomeric fatty acids and tumorigenesis: a commentary on recent work. (1985) (8)
Modification of mammary carcinogenesis and tissue peroxidation by selenium deficiency and dietary fat. (1981) (7)
Lack of effect of dietary fat on the growth and estrogen sensitivity of the MT-W9B transplantable mammary tumor. (1981) (7)
Anticarcinogenic effect of selenium in the dimethylbenz(a)anthracene-induced mammary tumor model in rats (1984) (6)
Augmented suppression of androgen receptor signaling by a combination of α‐tocopheryl succinate and methylseleninic acid (2006) (6)
BCG-modulated mammary carcinogenesis is dependent on the schedule of immunization but is not affected by dietary fat. (1986) (6)
Is Selenium Metabolism Necessary for Its Anticarcinogenic Activity (1989) (5)
Changes in ornithine decarboxylase activity and polyamine levels in response to eight different forms of selenium. (1991) (5)
The Impact of Calorie Restriction on Mammary Cancer Development in an Experimental Model (1991) (4)
In Vitro and in Vivo Studies of Methylseleninic Acid : Evidence That a Monomethylated Selenium Metabolite Is Critical for Cancer Chemoprevention 1 (2000) (4)
Serum and tumor sialyltransferase activities in women with breast cancer. (1986) (3)
Selenium and carcinogenesis (1985) (3)
Interaction of selenium deficiency and fat intake in the regulation of enzymes associated with peroxide metabolism (1983) (2)
Workshop on individual fatty acids and cancer : proceedings of a symposium held in Washington, DC, June 4-5, 1996 (1997) (2)
Modulation of Mammary Carcinogenesis by Eicosanoid Synthesis Inhibitors in Rats Fed High Levels of Linoleate (1991) (1)
The anticancer effects of vaccenic acid in milk fat are due to its conversion to conjugated linoleic acid via ∆ 9-desaturase (2004) (1)
Dietary Fat and Mammary Carcinogenesis (1986) (1)
498 PROSTATE CANCER CELLS DIFFER IN TESTOSTERONE ACCUMULATION, DIHYDROTESTOSTERONE CONVERSION, AND ANDROGEN RECEPTOR SIGNALING RESPONSE TO STEROID 5α-REDUCTASE INHIBITORS (2013) (1)
Selenium and Cancer Prevention (2006) (1)
Introduction: Prevention of Breast Cancer--Present Reality and Future Promise (2004) (1)
232: Activation of Androgen Receptor by Hypoxia in Prostate Cancer: Its Clinical and Biological Implications (2005) (1)
Peering down the kaleidoscope of thiol proteomics and unfolded protein response in studying the anticancer action of selenium (2006) (1)
2458 : High Superoxide Dismutase (SOD) and Low Glutathione Peroxidase (GPX) Activities in Red Blood Cells (RBCs) Predict Susceptibility of Lung Cancer Patients to Radiation Pneumonitis (2006) (0)
Tumor markers and their significance in the management of breast cancer : proceedings of a workshop held in Bethesda, Maryland, March 6, 1985 (1986) (0)
Similarity between frans Fat and Saturated Fat in the Modification of Rat Mammary Carcinogenesis1 (2006) (0)
Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in prostate cancer cells through enhancing caspase activation (2005) (0)
Effect of Estradici and Prolactin on Galactosyltransferase and a-Lactalbumin Activities in Rat Mammary Gland and Mammary Tumor1 (2006) (0)
Cancer Cells Hypoxia Increases Androgen Receptor Activity in Prostate (2006) (0)
Prophylaxis of Mammary Neoplasia by Selenium Supplementation in the Initiation and Promotion Phases of Chemical Carcinogenesis1 (2006) (0)
Dedication: Clifford W. Welsch (2005) (0)
New leads on vitamin E succinate-induced apoptosis signaling in prostate cancer cells (2004) (0)
Selenium-mediated inhibition of mammary carcinogenesis (1983) (0)
Selenium decreases prostate specific antigen expression by inducing protein degradation and suppressing mRNA abundance (2004) (0)
Failure of interventions to maintain mitochondrial function in ischemic myocardium. (1980) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Clements Ip?

Clements Ip is affiliated with the following schools: